Latest news
Search news stories
Enter a keyword to search news.
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology .
[Read more about ENZAMET shows promise as prostate cancer treatment ]
